 This trial will determine the maximal dose of Busulfex that can be given in a two, three, or four day period with acceptable toxicity to myeloma patients, who either are or 65 years of age or have renal insufficiency, defined as creatinine 3gdL or creatinine clearance 30 mlmin. 